The recent surge in funding into boutique pharmaceutical companies, particularly those focusing on novel therapies and challenging drug development programs, has fueled what some are calling "High Investor Pharma." https://jemimafiwp928065.newsbloger.com/40782429/elite-roller-pharma-speculative-bet